Medicaid COPD Drug Spending Rose to $1.78 Billion Between 2008 and 2023
A 16-year analysis of U.S. Medicaid data found that COPD medication spending reached $1.78 billion in 2023 despite enrollee-adjusted prescription ...
A 16-year analysis of U.S. Medicaid data found that COPD medication spending reached $1.78 billion in 2023 despite enrollee-adjusted prescription ...
A multicenter retrospective electronic medical record study in India found that pantoprazole was the most frequently prescribed proton pump inhibitor ...
A retrospective cohort study of 877 US adults found that rozanolixizumab has been initiated in a broad myasthenia gravis population, ...
A cross-sectional study of 197 hypertensive outpatients at Karnali Academy of Health Sciences in Jumla, Nepal, found generic prescribing at ...
A German prescription database analysis of 289 patients found acoramidis was initiated mainly as first-line therapy for older, predominantly male ...
A new editorial synthesizes 27 pharmacoepidemiology studies showing how real-world chronic disease care, from FAERS safety signals to national insurance ...
A retrospective analysis of Indian electronic medical records found oral minocycline was prescribed mostly for acne, with adverse events documented ...
A nationwide French cohort study describes the first 257 patients treated with sotatercept for pulmonary arterial hypertension since its June ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.